Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$1.88 - $4.06 $1,975 - $4,267
-1,051 Reduced 8.74%
10,975 $33,000
Q1 2022

May 17, 2022

BUY
$2.78 - $4.7 $33,432 - $56,522
12,026 New
12,026 $40,000
Q4 2021

Feb 17, 2022

SELL
$3.87 - $6.9 $46,211 - $82,392
-11,941 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$5.39 - $8.44 $64,361 - $100,782
11,941 New
11,941 $75,000

Others Institutions Holding LEXX

About Lexaria Bioscience Corp.


  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $13.7M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.